Alzheimer’s research is having a moment, and the discovery of novel biomarkers is enabling progress far beyond diagnostics.
Global healthcare communications company SCIRIS is delighted to announce the appointment of Isaac Batley as new CEO.
A Japanese biotech firm says it has developed the world’s first early screening test for pancreatic cancer, using the powerful noses of tiny worms.
Prosecutors, who are seeking a 15-year prison sentence, called Holmes’ fraud “among the most substantial white collar offenses Silicon Valley or any other district has seen.”
When Theranos was formed in 2003, it promised to be the end-all and be-all of medical testing, a one-stop diagnostic shop from a single finger-prick of blood. What it actually did, as the world now knows, was perpetrate fraud on a massive scale, fooling its board of directors, investors and – worst of all – the physicians and patients who trusted the company to deliver accurate test results.
After 14 years at the top, Roche Chief Executive Officer Severin Schwan will step down from his role at the helm of the Swiss pharma giant next year. He will become the new chairman of the company’s board of directors upon the retirement of current chair Christoph Franz.
Ramesh “Sunny” Balwani, Elizabeth Holmes’ former business and romantic partner and former COO of Theranos, was found guilty of all 12 fraud charges brought against him for his role in the Theranos scandal. In 2018, he, along with Holmes, was charged with multiple counts of wire fraud and conspiracy to commit fraud.
Providers continue to adapt to the new care models to patients’ needs. As the pandemic wreaked havoc across the United States, healthcare providers started deploying various health IT solutions to address emerging challenges. They aimed to reduce the load on doctors and protect clinicians and patients from the virus exposure.
Rune Labs on Monday said the San Francisco-based startup has received clearance from the U.S. Food and Drug Administration to use the Apple Watch to monitor tremors and other common symptoms in patients with Parkinson’s disease.
A team involving researchers from Alcediag, Montpellier University Hospital, Les Toises Psychiatry Centre in Lausanne and Professor David J. Kupfer from the University of Pittsburgh identified and validated a combination of blood biomarkers specific to bipolar disorder. These results, recently published in the leading scientific journal Nature, have led to the development of the first diagnostic blood test for this disorder that affects more than 60 million people worldwide.